Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalNo recent work listed

Hou‐Quan Tao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0609-9203; OpenAlex author ID A5041378395. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways. Last author DOI 10.1002/jcb.29533↗
  2. REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9. Last author DOI 10.1111/cas.12018↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xujun He · 2 shared papers, 2012–2021 · strength 0.22
  2. Rulin Sun · 1 shared paper, 2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.